About the Oncology Vaccines Session
Oncology vaccines represent a promising frontier in cancer research, offering potential avenues for prevention, treatment, and immunotherapy. These vaccines aim to harness the body's immune system to recognize and target cancer cells specifically. Unlike traditional vaccines that prevent infectious diseases, oncology vaccines stimulate the immune system to recognize cancerous cells as foreign invaders and mount an immune response against them. They can be designed to target tumor-specific antigens or antigens shared by multiple cancer types. Additionally, oncology vaccines can be used in combination with other therapies, such as chemotherapy or checkpoint inhibitors, to enhance their effectiveness. While still in early stages, ongoing research and clinical trials show encouraging results, paving the way for the development of novel and personalized cancer treatment strategies.
Topics Covered in Oncology Vaccines
Neoantigen Vaccines
Dendritic Cell Vaccines
Nucleic Acid Vaccines
Vaccine Adjuvants
Checkpoint Combinations
HPV Vaccination
Related Scientific Sessions at CIOC 2027
Why Attend the Oncology Vaccines Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Oncology Vaccines work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Oncology Vaccines research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Oncology Vaccines track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Oncology Vaccines Conference 2027 — FAQs
What is the Oncology Vaccines track at CIOC 2027?
The Oncology Vaccines track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Oncology Vaccines. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Oncology Vaccines sessions?
Cancer researchers and clinicians, educators and students with an interest in Oncology Vaccines are all welcome — whether presenting or attending.
Can I present my research in the Oncology Vaccines track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Oncology Vaccines sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Oncology Vaccines track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.